99% Purity Aripiprazole Powder Pharmaceutical Intermediate Aripiprazole Material Aripiprazole
Product Description
Product Details
Product Name |
Aripiprazole |
CAS No. |
129722-12-9 |
MF |
C23H27Cl2N3O2 |
MW |
448.388 |
Appearance and shape |
White powder |
Aripiprazole is a novel high-fat soluble quino-line derivative, which is characterized by its pharmacological action as both postsynaptic dopamine D2 receptor antagonist and presynaptic dopamine D2 receptor agonist. It also activates D1, D3, and D4 receptors;It has dual effects of partial receptor antagonism or activation on 5-HT1A receptor. It has completely antagonistic effect on 5-HT2A receptor. This characteristic is different from the first generation and atypical antipsychotics, that is, the second generation antipsychotics, so it is called the dopamine system Chemicalbook stabilizer or the third generation antipsychotics. Since the past, it is mainly used in the treatment of schizophrenia, schizoaffective psychosis and other psychotic disorders. According to relevant literature reports, aripiprazole has obvious curative effect on positive and negative symptoms, anxiety, depression, and cognitive function of schizophrenia, with higher safety. It has also been reported to treat other mental disorders, such as mood disorders manic episodes, senile dementia with mental disorders, anxiety disorders, childhood conduct disorders, depression, etc.
Application & Function
1. Aripiprazole is a psychotropic agent belonging to the chemical class of benzisoxazole derivatives and is indicated for the treatment of schizophrenia. A selective dopamine D2-receptor antagonist with dopamine autoreceptor agonist activity.
2. Aripiprazole for the treatment of schizophrenia and related psychotic disorders.
3. Aripiprazole is sometimes super-indicated for the treatment of other psychotic disorders (e.g. delusional disorders), dementia-related behavioural disorders, childhood and adolescent behavioural disorders, impulse control-related disorders, etc.
Specification